Clinical Trials Browser

Phase 1/2 × Unknown × Idarubicin × Clear all

NCT04112589 2022-03-14

A Clinical Trial to Assess the Efficacy and Safety of the Combination of a Drug Call Quizartinib With Chemotherapy (FLAG-IDA) in Patients With Acute Myeloid Leukemia That Has Not Responded to the First Treatment or That Has Returned After the First Treatment

Phase 1/2 Unknown

63 enrolled

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT00838240 2012-07-20

AML-14A

Phase 1/2 Unknown

114 enrolled

MyeloidOther hematologic neoplasm

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Acute

NCT01534702 2012-02-20

CIARA

Phase 1/2 Unknown

60 enrolled

Other hematologic neoplasm

Leukemia, Myeloid, Acute